N-(m-PEG4)-N'-(hydroxy-PEG2)-Cy5 22744 d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine

d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine

J Microencapsul

Pre-treatment of H9c2 rat myoblasts with sulforaphane decreases the apoptotic cell number and the expression of pro-apoptotic proteins (Bax

Smiles: OC1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

Blood Cancer J

N-(m-PEG4)-N'-(hydroxy-PEG2)-Cy5 22744 d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidineN (m PEG4) N' (hydroxy PEG2) Cy5 is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 2107273 12 9 Molecular Weight: 713. 34 Formula: C40H57ClN2O7 Chemical Name: 2 [(1E,3E) 5 [(2E) 3,3 dimethyl 1 (2,5,8,11 tetraoxatridecan 13 yl) 2,3 dihydro 1H indol 2 ylidene]penta 1,3 dien 1 yl] 1 {2 [2 (2 hydroxyethoxy)ethoxy]ethyl} 3,3 dimethyl 3H indol 1 ium chloride Smiles: [Cl ]. COCCOCCOCCOCCN1 C(=C C=C C=C